Cas:3225-74-9 2-Amino-1-(2-fluorophenyl)ethanol manufacturer & supplier

We serve Chemical Name:2-Amino-1-(2-fluorophenyl)ethanol CAS:3225-74-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Amino-1-(2-fluorophenyl)ethanol

Chemical Name:2-Amino-1-(2-fluorophenyl)ethanol
CAS.NO:3225-74-9
Synonyms:2-Amino-1-(2-fluorophenyl)ethanol;Benzenemethanol, α-(aminomethyl)-2-fluoro-
Molecular Formula:C8H10FNO
Molecular Weight:155.169
HS Code:2922199090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:287.4±25.0 °C at 760 mmHg
Density:1.2±0.1 g/cm3
Index of Refraction:1.549
PSA:46.25000
Exact Mass:155.074646
LogP:0.51

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-Amino-1-(2-fluorophenyl)ethanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzenemethanol, α-(aminomethyl)-2-fluoro- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Amino-1-(2-fluorophenyl)ethanol Use and application,2-Amino-1-(2-fluorophenyl)ethanol technical grade,usp/ep/jp grade.


Related News: Patients having Zynteglo treatment for beta thalassaemia also need conditioning treatment to clear out their bone marrow cells before receiving Zynteglo. Healthcare professionals should therefore explicitly inform patients receiving Zynteglo of the increased risk of blood cancers from medicines used in conditioning treatments. 3-amino-N-(4-methoxyphenyl)-5-(methylthio)-2-oxo-2H-pyrrole-4-carboxamide manufacturers Denise Bowser, commercial director at Onyx, commented, “Over the years, we have worked towards building a strong reputation in helping drug developers with complex chemistry. 2-hydroxyethyl-dimethyl-(1-phenothiazin-10-ylpropan-2-yl)azanium suppliers Though the program obtained priority review from FDA back in November, analysts expressed skepticism in July 2020 after it failed to prove superior to the companies’ other drug Lumizyme in improving respiratory function in a Phase III trial. Acetic acid, [4-[(dipropylamino)sulfonyl]-2-methylphenoxy]-, hydrazide vendor & factory.